Timing matters: early antiplatelet therapy optimizes alteplase treatment in acute ischemic stroke
Background The optimal timing for initiating antiplatelet therapy (APT) after intravenous alteplase in acute ischemic stroke (AIS) remains unclear, due to concerns about intracranial hemorrhage. This study evaluated the safety and efficacy of early APT (≤24 h post-alteplase) versus standard APT (>24...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2026-12-01
|
| シリーズ: | Annals of Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2610115 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|